Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7532849 | 0.92 | EDNRA (0.83) | EDNRAEDNRB | |
| SCHEMBL7538653 | 0.92 | EDNRA (0.79) | EDNRAEDNRB | |
| SCHEMBL7809560 | 0.91 | EDNRA (0.81) | EDNRAEDNRB | |
| SCHEMBL7532068 | 0.91 | EDNRA (0.81) | EDNRAEDNRB | |
| SCHEMBL4585578 | 0.90 | EDNRA (0.85) | EDNRAEDNRB | |
| SCHEMBL8091934 | 0.90 | EDNRA (0.85) | EDNRAEDNRB | |
| SCHEMBL8203979 | 0.90 | EDNRA (0.93) | EDNRAEDNRB | |
| SCHEMBL6956238 | 0.90 | EDNRA (0.85) | EDNRAEDNRB | |
| SCHEMBL13038489 | 0.90 | EDNRA (0.93) | EDNRAEDNRB | |
| SCHEMBL8208036 | 0.89 | EDNRA (0.78) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6087389-A | TREATING CARDIOVASCULAR AND RENAL DISEASES INCLUDING HYPERTENSION, ACUTE AND CHRONIC RENAL FAILURE, CYCLOSPORINE INDUCED NEPHROTOXICITY, STROKE, CEREBROVASCULAR VASOSPASM, MYOCARDIAL ISCHEMIA, ANGINA, HEART FAILURE, ATHEROSCLEROSIS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-11 | — | — | US | disclosed |
| US-5817693-A | Endothelin receptor antagonists | SMITHKLINE BEECHAM CORPORATION | 1998-10-06 | — | — | US | disclosed |
| US-5719183-A | HYPOTENSIVE AGENTS; KIDNEY DISEASES; ANTIISCHEMIC AGENTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |
| US-5719182-A | TREATING HYPERTENSION, RENAL FAILURE, CEREBROVASCULAR DISEASE | SMITHKLINE BEECHAM CORPORATION (US) | 1998-02-17 | — | — | US | disclosed |